Table 6.
Pneumococcal vaccination in 2015–2016 and 2017–2018 by gender, locality, and vaccine.
| Variable | Pneumococcal Vaccination N (%) | Completed Schedule N (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | p | Vaccinated Completely | Not Fully Vaccinated | Not Vaccinated | p | |||
| Gender | 2015–2016 | Male | 228 (58.9) | 159 (41.1) | 0.393 | 228 (58.9) | 49 (12.7) | 110 (28.4) | 0.635 |
| Female | 228 (62.0) | 140 (38.0) | 228 (62.0) | 40 (10.9) | 100 (27.2) | ||||
| 2017–2018 | Male | 380 (85.4) | 65 (14.6) | 0.532 | 380 (85.4) | 50 (11.2) | 15 (3.4) | 0.817 | |
| Female | 332 (84.1) | 63 (15.9) | 332 (84.1) | 50 (12.7) | 13 (3.3) | ||||
| Place | 2015–2016 | Urban area | 364 (57.8) | 266 (42.2) | <0.001 | 364 (57.8) | 77 (12.2) | 189 (30.0) | 0.003 |
| Rural area | 92 (73.6) | 33 (26.4) | 92 (73.6) | 12 (9.6) | 21 (16.8) | ||||
| 2017–2018 | Urban area | 569 (82.7) | 119 (17.3) | <0.001 | 569 (82.7) | 94 (13.7) | 25 (3.6) | 0.002 | |
| Rural area | 143 (94.1) | 9 (5.9) | 143 (94.1) | 6 (3.9) | 3 (2.0) | ||||
| Vaccine | 2015–2016 | PCV10 1 | — | — | — | 126 (83.4) | 25 (16.6) | — | 0.930 |
| PCV13 2 | — | — | 330 (83.8) | 64 (16.2) | — | ||||
| 2017–2018 | PCV10 1 | — | — | — | 574 (88.3) | 76 (11.7) | — | 0.279 | |
| PCV13 2 | — | — | 138 (85.2) | 24 (14.8) | — | ||||
1 PCV10—10-valent conjugate pneumococcal vaccine; 2 PCV13—13-valent conjugate pneumococcal vaccine.